Commercialization: Page 83
-
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Deirdre CONNELLY GlaxoSmithKline Selects Head of North American Pharma Business Deirdre Connelly, former president of U.S. operations at Eli Lilly, has joined GlaxoSmithKline (GSK) as president, North American pharmaceuticals. Ms. Connelly was appointed president of U.S. opera...
By PharmaVoice Team • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, marketing, And R&D Trends affectinga the healthcare industry EU Candidate Countries Offer Ripe Field for Clinical-Trial Recruitment Conducting clinical trials in Europe is not a new concept for global pharmaceutical companies, but choosing the country in which to hold a particular tria...
By PharmaVoice Team • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by Ken Begasse Jr. The Changing sales model provides greater value for customers Over the past few years, the practice of healthcare has changed significantly, forcing marketers to reevaluate their strategies, tools, and tactics. One change has been to reverse the previous trend towar...
By Ken Begasse Jr. • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
Upfront
Milestones kinetix turns 10 Kinetix, a specialized healthcare consulting firm that uses exclusive, proprietary communication channels to build and implement live and online marketing programs, is celebrating its 10th anniversary. Over the last 10 years, Kinetix has developed strategies to communi...
By PharmaVoice Team • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
Raise Your Voice
A winter of discontent Oh, yes, change is in the air. Alan Greenspan is humbled before a congressional committee, forced to admit that perhaps, just perhaps, his faith in the market was misplaced. If this paragon of libertarianism finds himself nonplussed, it is no surprise that lesser lights amo...
By PharmaVoice Team • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Global is as global does A New World Order Welcome to the first annual Going Global special issue. We recognize that spanning the globe like Jim McKay is no easy feat and impossible to do in one publication, but we hope to avoid the agony of defeat as we bring you a sampling of the trends and eve...
By Taren Grom • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
Venture Capital: Funding Challenges
VENTURE CAPITAL: CAUTIOUS investment Venture capital firms are sitting on massive funds and are still doing deals, but their energies are focused on reinvesting in portfolio companies and safer latest age deals. As a result, it has never been harder for the early stage pure startup to get funded....
By PharmaVoice Team • Feb. 23, 2009 -
PharmaVoice Team/PharmaVoice
A Community Approach
As many pharmaceutical companies are finding, healthcare begins within the community, and a regional program, with health information that helps patients at a local level, might just win a company the hearts, minds, and ultimately buying power of those community members. For an industry confronte...
By PharmaVoice Team • Feb. 23, 2009 -
PharmaVoice Team/PharmaVoice
Delivering on the Promise
BY ELISABETH PENA Drug delivery promises FULLER PIPELINES, EXTENDED PRODUCT LIFE CYCLES, and IMPROVED PATIENT COMPLIANCE. AS THE PHARMACEUTICAL INDUSTRY FACES A FLOOD OF BLOCKBUSTER DRUG PATENT EXPIRATIONS, drug-delivery COMPANIES WILL HAVE THE CHANCE TO PROVE THEMSELVES. BY 2005 analysts predict...
By PharmaVoice Team • Feb. 23, 2009 -
PharmaVoice Team/PharmaVoice
PharmaTrax
SALES, MARKETING, AND R&D TRENDS AFFECTING THE HEALTHCARE INDUSTRY GENERICS SECTOR Expected to Double by 2007 According to Datamonitor, by 2007 the generics market is expected to be valued at $57 billion, more than twice its estimated value of $27 billion in 2001. Researchers at the company c...
By PharmaVoice Team • Feb. 22, 2009 -
PharmaVoice Team/PharmaVoice
For Art's Sake
There are a handful of “classic” pharmaceutical healthcare ads. Ads that stand the test of time and follow the basic tenets of good advertising. Once again, Abelson-Taylor’s ad campaign for Hytrin has been identified as such a classic. According to Don Martiny, the Hytrin Balloon campaign, which ...
By PharmaVoice Team • Feb. 22, 2009 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
A WHOLE NEW MEANING TO JUNK MAIL If you are depressed that the only things you seem to receive in the mail are bills, there may be a cure. Last summer, some sales representatives in southern Florida allegedly orchestrated a promotional scheme, with the cooperation of one or more physician practic...
By Brian P. Waldman • Feb. 22, 2009 -
PharmaVoice Team/PharmaVoice
PharmaCase
Making a case for PATIENT EDUCATION Patient ed project puts pharma company on ‘Write track’ with cancer patients EVER CONSIDER PITCHING YOUR BOSS ON A LARGE-SCALE PATIENT EDUCATION PROJECT THAT: A.) WOULD BE VERY EXPENSIVE, B.) WOULD NOT DIRECTLY SUPPORT ANY OF YOUR PRODUCTS, AND C.) WOULD DEFY A...
By PharmaVoice Team • Feb. 22, 2009 -
PharmaVoice Team/PharmaVoice
What's on your mind: Opinions
OPINIONS Information standards In the November/December issue of PharmaVOICE, we asked if the Food and Drug Administration should consider relaxing its standards for press releases about drug approvals, which currently are almost always considered a promotion. The regulatory agency issued a call ...
By PharmaVoice Team • Feb. 22, 2009 -
PharmaVoice Team/PharmaVoice
Raise Your Voice: Letters
LETTERS Two critical areas of success Missed Opportunities Your article on “The Patient Pipeline” highlighted many of the difficulties in patient accrual and retention. Unfortunately the solutions in my opinion missed two critical success factors. As CEO and cofounder of MCSI, the largest U.S.-b...
By PharmaVoice Team • Feb. 22, 2009 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Funding in a closed space The healthcare private equity market was down in 2002, and industry experts don’t expect a gr eat deal of improvement in 2003. Venture capital firms are sit ting on massive funds and are still doing deals, but according to Russell LaMontagne, president and founder of Cor...
By Taren Grom • Feb. 22, 2009 -
PharmaVoice Team/PharmaVoice
Information Technology: Tracking the E-Volution
Pharmaceutical companies have long term plans, they have products that take a long time to develop, a long time to test to gain approval, and they have a shelf life. But technology moves so much faster than that. So the industry as a whole has had to adopt to the speed of technology. IAN CROSS BY...
By PharmaVoice Team • Feb. 21, 2009 -
PharmaVoice Team/PharmaVoice
Middle Markets
Blockbuster drugs are sexy, exciting, and they generate widespread attention. They monopolize the advertising budgets of their marketers and developers, who work to ensure that their attributes are seen by millions of consumers via television and in magazines. As a result of the Herculean promoti...
By Deborah Ruriani • Feb. 21, 2009 -
PharmaVoice Team/PharmaVoice
The Practice of Public Relations
When effectively managed, public relations creates unique opportunities for marketers to provide con sumers and healthcare professionals with immediate and thorough drug and healthcare information. The healthcare publicrelations market in the United States grew 30% last year and is now valued at ...
By PharmaVoice Team • Feb. 21, 2009 -
PharmaVoice Team/PharmaVoice
Talent Pool
business operation functions and reports to TPNA President Alan MacKenzie. “We are delighted to have Mark join our executive team,” Mr. MacKenzie says. “He will play an important role in TPNA’s contin ued growth and his extensive background and general management experience in the phar maceutical...
By PharmaVoice Team • Feb. 17, 2009 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Aging female population presents NEW CHALLENGES in HRT MARKET The growing number of postmenopausal women translates into new challenges for clinicians and is leading to increased focus on the hormone replacement therapy market. Hormone Replacement Therapy, a study from Decision Resources Inc., id...
By PharmaVoice Team • Feb. 17, 2009 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Creative Review Wow! If a picture could say a zillion words, it would be this one. Don’t get mewrong, I’m a lover and strong advocate for incredibly intriguing copy, but when there is an image like this one — how could one not be affected? This picture couldn’t depict empowerment,strength,and the...
By PharmaVoice Team • Feb. 17, 2009 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Brand is not a color or a single image or a typeface. It is also not a cartoon character, illustration, or icon. While these are all elements of branding, when considered individually, they merely represent a product or service. A brand is a promise — a promise of benefit to your tar get audience...
By Mike Myers and Guy Mastrion • Feb. 17, 2009 -
PharmaVoice Team/PharmaVoice
What's on Your Mind: Opinions
Is a fee based appointment plan a reasonable strategy? In the September/October issue, PharmaVOICE asked readers to respond to a recent program being implemented by a Cincinnatibased physician group. Queen City Physicians group created a separate, limited liability corporation to schedule 10 minu...
By PharmaVoice Team • Feb. 17, 2009 -
PharmaVoice Team/PharmaVoice
Raise Your Voice: Letters
RAISE your voice Great article. It reminds me that it is necessary to always push the envelope of acceptable to achieve the exceptional. What we create should not be “unsurpassed efficacy” but rather an experience. Unfortunately what I see are designers who have the drive but clients who fear str...
By PharmaVoice Team • Feb. 17, 2009
Previous
